Renal complications of high-dose chemotherapy and peripheral blood stem cell transplantation

被引:15
作者
Herget-Rosenthal, S
Uppenkamp, M
Beelen, D
Kohl, D
Kribben, A
机构
[1] Univ Essen Gesamthsch Klinikum, Abt Nieren & Hochdruckkrankheiten, Med Klin & Poliklin, D-45122 Essen, Germany
[2] Univ Essen Gesamthsch Klinikum, Klin Knochenmarktransplantat, D-45122 Essen, Germany
来源
NEPHRON | 2000年 / 84卷 / 02期
关键词
acute renal failure; nephrotoxicity; peripheral blood stem cell transplantation proteinuria; sepsis;
D O I
10.1159/000045561
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Following bone marrow transplantation, acute renal failure and proteinuria are common complications with a high mortality, particularly in patients requiring hemodialysis, Incidence, potential predisposing factors, and outcome of acute renal complications in patients with hematological malignancies receiving autologous peripheral blood stem cell transplantation were prospectively studied in 53 patients. Eight patients developed acute renal failure. Three of them required hemodialysis, Of all patients with acute renal failure, only those requiring hemodialysis died, due to nonrenal causes. Only 1 of the 45 patients without renal failure died. Mild proteinuria of predominantly tubular origin occurred in 16 patients, in 3 with and in 13 without acute renal failure. As predisposing factors for acute renal failure were identified: renal hypoperfusion due to systemic inflammatory response syndrome, sepsis or septic shock, and combined administration of nephrotoxic drugs. Especially those patients receiving high numbers of nephrotoxic drugs in combination with renal hypoperfusion were likely to develop acute renal failure. These results suggest that patients receiving high-dose chemotherapy and autologous peripheral blood stem cell transplantation have a low risk of developing acute renal failure and proteinuria, Copyright (C) 2000 S. Karger AG, Basel.
引用
收藏
页码:136 / 141
页数:6
相关论文
共 41 条
[1]   Nephrotoxicity of high-dose ifosfamide/carboplatin/etoposide in adults undergoing autologous stem cell transplantation [J].
Agaliotis, DP ;
Ballester, OF ;
Mattox, T ;
Hiemenz, JW ;
Fields, KK ;
Zorsky, PE ;
Goldstein, SC ;
Perkins, JB ;
Rosen, RM ;
Elfenbein, GJ .
AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 1997, 314 (05) :292-298
[2]   NON-OLIGURIC ACUTE RENAL-FAILURE [J].
ANDERSON, RJ ;
LINAS, SL ;
BERNS, AS ;
HENRICH, WL ;
MILLER, TR ;
GABOW, PA ;
SCHRIER, RW .
NEW ENGLAND JOURNAL OF MEDICINE, 1977, 296 (20) :1134-1138
[3]  
BETTER OS, 1990, NEW ENGL J MED, V322, P825
[4]  
Bokemeyer C, 1997, CANCER, V80, P1221, DOI 10.1002/(SICI)1097-0142(19971001)80:7<1221::AID-CNCR4>3.3.CO
[5]  
2-P
[6]   DEFINITIONS FOR SEPSIS AND ORGAN FAILURE AND GUIDELINES FOR THE USE OF INNOVATIVE THERAPIES IN SEPSIS [J].
BONE, RC ;
BALK, RA ;
CERRA, FB ;
DELLINGER, RP ;
FEIN, AM ;
KNAUS, WA ;
SCHEIN, RMH ;
SIBBALD, WJ .
CHEST, 1992, 101 (06) :1644-1655
[7]   NEPHROTOXICITY ASSOCIATED WITH COMBINED GENTAMICIN-AMPHOTERICIN-B THERAPY [J].
CHURCHILL, DN ;
SEELY, J .
NEPHRON, 1977, 19 (03) :176-181
[8]   RENAL DYSFUNCTION DURING HIGH-DOSE CISPLATIN THERAPY AND AUTOLOGOUS HEMATOPOIETIC STEM-CELL TRANSPLANTATION - EFFECT OF AMINOGLYCOSIDE THERAPY [J].
COOPER, BW ;
CREGER, RJ ;
SOEGIARSO, W ;
MACKAY, WL ;
LAZARUS, HM .
AMERICAN JOURNAL OF MEDICINE, 1993, 94 (05) :497-504
[9]  
ELIAS AD, 1995, BONE MARROW TRANSPL, V15, P373
[10]   MAXIMUM-TOLERATED DOSES OF IFOSFAMIDE, CARBOPLATIN, AND ETOPOSIDE GIVEN OVER 6 DAYS FOLLOWED BY AUTOLOGOUS STEM-CELL RESCUE - TOXICITY PROFILE [J].
FIELDS, KK ;
ELFENBEIN, GJ ;
LAZARUS, HM ;
COOPER, BW ;
PERKINS, JB ;
CREGER, RJ ;
BALLESTER, OF ;
HIEMENZ, JH ;
JANSSEN, WE ;
ZORSKY, PE .
JOURNAL OF CLINICAL ONCOLOGY, 1995, 13 (02) :323-332